Opioid use disorder (OUD) is a chronic medical condition in which a person’s use of opioids, whether prescription painkillers, heroin, or synthetic drugs like fentanyl, becomes compulsive and continues despite serious harm to their health, relationships, or daily life. It is diagnosed when someone meets at least 2 of 11 specific behavioral and physical criteria within a single year. OUD affects millions of people in the United States and was linked to more than 55,000 overdose deaths in 2024 alone.
How Opioids Change the Brain
Opioids work by binding to receptors on brain cells called mu opioid receptors. When activated, these receptors trigger a flood of dopamine, the brain’s primary reward chemical, producing intense feelings of pleasure and pain relief. This is the same reward system the brain uses to reinforce survival behaviors like eating and social bonding, which is why the pull toward opioids can feel so powerful.
With repeated use, the brain adapts. Cells become less responsive to the same dose, a process called tolerance, meaning a person needs more of the drug to feel the same effect. At the same time, the brain’s own ability to produce feelings of well-being diminishes. Stress, anxiety, and obsessive-compulsive circuits become more active. Eventually, a person may use opioids not to feel good but simply to avoid feeling terrible. These cellular and chemical changes are real, measurable alterations in brain function, which is why OUD is classified as a brain disorder rather than a failure of willpower.
Signs of Opioid Use Disorder
OUD shows up in patterns of behavior, not just physical symptoms. The diagnostic criteria include taking opioids in larger amounts or for longer than intended, wanting to cut back but being unable to, spending excessive time obtaining or recovering from opioids, and experiencing strong cravings. A person might also give up hobbies, social activities, or responsibilities at work or home. Using opioids in physically dangerous situations, like driving, or continuing to use despite knowing they’re causing health or relationship problems are also hallmarks.
Tolerance and withdrawal round out the list, though these two don’t count toward a diagnosis if someone is taking opioids exactly as prescribed under medical supervision. Severity depends on how many criteria a person meets: 2 to 3 is considered mild, 4 to 5 moderate, and 6 or more severe.
What Intoxication Looks Like
Acute opioid intoxication typically involves euphoria and heavy drowsiness. The pupils constrict to pinpoints. Breathing slows, sometimes dangerously. Other signs include nausea, constipation, flushing, itching, low blood pressure, and a drop in body temperature. The most life-threatening effect is respiratory depression: breathing becomes so shallow or slow that it can stop entirely.
What Withdrawal Feels Like
Withdrawal symptoms can begin as early as 4 hours after the last dose of a short-acting opioid like heroin. They typically peak between 48 and 72 hours and subside within about a week. Early symptoms include anxiety, intense drug cravings, sweating, yawning, runny nose, and watery eyes. As withdrawal progresses, muscle twitching, goosebumps, rapid heartbeat, fever, chills, stomach cramps, nausea, vomiting, and diarrhea can develop. Withdrawal is extremely uncomfortable but rarely life-threatening on its own. The greater danger is that the intense discomfort drives people back to using, often at doses their body can no longer tolerate, which raises the risk of overdose.
Risk Factors
Genetics play a meaningful role. Twin studies estimate that 38% to 61% of the variation in opioid addiction risk across a population comes from inherited factors. The gene most consistently linked to OUD is OPRM1, which provides the blueprint for the mu opioid receptor itself. Variations in this gene can affect how strongly a person responds to opioids and how vulnerable they are to dependence.
Environmental factors layer on top of genetic predisposition. A history of trauma, chronic pain, early exposure to substance use in the household, poverty, and lack of social support all increase risk. Mental health conditions are a major contributor as well: among people with OUD, roughly 36% have depression, 29% have an anxiety disorder, 21% have ADHD, and 18% have PTSD. Women with OUD are more likely to have co-occurring depression, anxiety, and PTSD than men. These conditions often fuel each other. Untreated anxiety or trauma can drive someone toward opioids for relief, and opioid use can worsen mental health over time.
The Overdose Crisis in Numbers
In 2024, synthetic opioids other than methadone (primarily fentanyl and its analogs) killed 47,735 people in the United States. Prescription opioids like oxycodone and hydrocodone accounted for another 7,989 deaths. There is some encouraging movement: overdose death rates dropped roughly 36% for synthetic opioids and 21% for prescription opioids between 2023 and 2024. Still, fentanyl remains the dominant driver of overdose deaths by a wide margin, largely because it contaminates other drug supplies and is potent enough that a tiny miscalculation can be fatal.
Treatment With Medication
The most effective treatments for OUD involve FDA-approved medications, sometimes called medications for opioid use disorder (MOUD). There are three main options, each working differently in the brain.
Methadone activates the same mu opioid receptors that other opioids do, but it’s long-acting and taken in controlled doses. It prevents withdrawal, reduces cravings, and blocks the euphoric rush from other opioids. It is dispensed as a liquid or dissolvable tablet, traditionally through specialized clinics that require regular visits.
Buprenorphine partially activates mu receptors, enough to ease withdrawal and cravings but with a ceiling effect that makes overdose less likely. It comes in several forms: daily dissolving tablets or films placed under the tongue, and monthly or weekly injections. Many formulations combine buprenorphine with naloxone to discourage misuse. Buprenorphine can be prescribed by physicians in office-based settings, making it more accessible than methadone for many people.
Naltrexone takes the opposite approach. It blocks mu receptors entirely, so if a person uses an opioid, they feel no effect. It is available as a monthly injection. Because it does not activate opioid receptors at all, a person must be fully detoxed before starting it, which can be a barrier.
Both buprenorphine and methadone have been shown to cut overdose mortality by up to half and significantly improve the odds that a person stays in treatment compared to counseling alone. Behavioral therapy, peer support groups, and treatment for co-occurring mental health conditions are valuable additions, but medication remains the backbone of effective OUD treatment.
Harm Reduction and Naloxone
Naloxone is a rescue medication that rapidly reverses an opioid overdose by displacing opioids from receptors in the brain. It is available as a nasal spray without a prescription in most states. Expanding access to naloxone and training people to use it has significantly reduced overdose mortality in communities where distribution programs are active.
Syringe service programs, which provide clean injection equipment, have been shown to cut HIV transmission and hepatitis C rates among people who inject drugs by as much as half. These programs also serve as entry points to treatment: studies consistently show they increase the percentage of people who eventually begin formal treatment, and they do not increase crime in the areas where they operate.